Join the club for FREE to access the whole archive and other member benefits.

Wild Biotech's unique database maps new targets for human diseases


Key points from article :

Wild Biotech boasting a database of more than 1,200 gut bacteria harvested from animals.

75% of these microbiota were previously unknown.

“Collected gut microbiota from almost 200 species of animals,” - Neta Raab, Co-founder & CEO at Wild Biotech.

"Database of over 5,000 microbial genomes from those animals," - Raab.

Wild’s database now comprises hundreds of animal species and 100 million genes.

Gut microbiota of animals is the most relevant and directly translatable to human therapeutics.

AI tools to identify proteins, peptides, bacteriophages and other agents with direct activity on targets in human diseases.

High-throughput synthetic biology to validate microbiome-derived agents and accelerate them into preclinical testing.

Identified over 2,000 CRISPR/Cas genome editing systems.

“Screen many millions of interactions with specific targets associated with human diseases,” - Raab.

Study published in the journal Science.

Huge database of wildlife gut microbiota could screen potential therapies within days

Mentioned in this article:

Company Representative

Co-founder and CEO


Peer-reviewed academic online journal of the American Association for the Advancement of Science (AAAS)


Israel-based preclinical stage company